With around 70 million obese people, the market for antiobesity drugs in India is growing steadily. One in four Indians is overweight, shows data from the National Family MAT* (in $cr) Health Survey (NFHS) 2022.
With around 70 million obese people, the market for antiobesity drugs in India is growing steadily. One in four Indians is overweight, shows data from the National Family MAT* (in $cr) Health Survey (NFHS) 2022.
0 Comments